NCT03622385 - Exploration of DNA Methylation as a Marker for Early Detection of High Grade Serous Epithelial Ovarian Cancer | Biotech Hunter

Enrollment

250

Participants

Timeline

Start Date

February 19, 2019

Primary Completion Date

March 8, 2022

Study Completion Date

March 8, 2022

Conditions

Epithelial Ovarian Cancer

Interventions

OTHER

DNA Methylation

No intervention will be performed. Blood and tissue samples will be analyzed for biomarkers that may be used to develop a diagnostic panel for early detection and diagnosis of high grade serous epithelial ovarian cancer.

Trial Locations (1)

75246

Baylor University Medical Center, Dallas